1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Metoclopramide |
| brand | String | Reglan, Gimoti (intranasal), Metozolv ODT |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Prokinetics|Prokinetic]] • [[:Category:Antiemetics|Antiemetic]] • [[:Category:Dopamine_D2_antagonists|Dopamine D2 antagonist]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000EF4-QINU`"', '"`UNIQ--vote-00000EF5-QINU`"', '"`UNIQ--vote-00000EF6-QINU`"', '"`UNIQ--vote-00000EF7-QINU`"', '"`UNIQ--vote-00000EF8-QINU`"' |
| starting_dose | String | 10 mg PO/IV/IM QID, '''not to exceed 12 weeks''' (tardive dyskinesia risk); intranasal Gimoti 15 mg BID |
| preparations | String | 5, 10 mg tablets; 5 mg/5 mL solution; 5 mg/mL IV; 15 mg/spray intranasal |
| fda_max | String | 40 mg/d |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV • IM • intranasal |
| onset | String | IV/IM 1-3 minutes; PO 30-60 minutes |
| duration | String | 4-6 hours |
| halflife | String | 5-6 hours'"`UNIQ--ref-00000EF9-QINU`"' |
| bioavailability | String | ~80% (oral; reduced by significant first-pass)'"`UNIQ--ref-00000EFA-QINU`"' |
| pregnancy | String | Widely used for hyperemesis gravidarum; reassuring data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US. Carries a '''Boxed Warning''' for '''tardive dyskinesia''' (irreversible movement disorder), driving the 12-week chronic-use limit'"`UNIQ--ref-00000EFB-QINU`"' |
